Novo Nordisk Pharmatech A/S
CVR 13246149 · Public limited company (A/S) · Active · Low risk
Novo Nordisk Pharmatech A/S is a Public limited company (A/S), founded on , based in Køge. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 2.4bn and a net result of DKK 113.9m.
Bankruptcy risk for Novo Nordisk Pharmatech A/S
0.0 × the average (1.41%) · higher risk than 0% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 13246149
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (37 years)
- Address
- Københavnsvej 216
4600 Køge - Municipality
- Køge
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 10.0m
- Employees
- 165 (2018)
- Auditor
- DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 31 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 79.6% |
| Current ratio | 192% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 4 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 0 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Revenue | DKK 1.0bn | DKK 956.0m |
| Gross profit | DKK 74.9m | DKK 72.7m |
| Net profit | DKK 113.9m | DKK 60.6m |
| Equity | DKK 2.4bn | DKK 1.3bn |
| Total assets | DKK 3.1bn | DKK 2.0bn |
| Cash | DKK 0 | – |
| Short-term debt | DKK 579.4m | – |
| Tax owed | DKK 22.6m | – |
| Avg. employees | 529 | – |
Latest annual report: Reporting class C, large enterprise · auditor's statement: Auditor's report on audited financial statements · DeloitteStatsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 99 | ||
| 1 Jan 2024 – 31 Dec 2024 | 106 | ||
| 1 Jan 2023 – 31 Dec 2023 | 95 | ||
| 1 Jan 2022 – 31 Dec 2022 | 88 | ||
| 1 Jan 2021 – 31 Dec 2021 | 118 | ||
| 1 Jan 2020 – 31 Dec 2020 | 81 | ||
| 1 Jan 2019 – 31 Dec 2019 | 114 | ||
| 1 Jan 2018 – 31 Dec 2018 | 84 | ||
| 1 Jan 2017 – 31 Dec 2017 | 137 | ||
| 1 Jan 2016 – 31 Dec 2016 | 74 | ||
| 1 Jan 2015 – 31 Dec 2015 | 152 | ||
| 1 Jan 2014 – 31 Dec 2014 | 29 | ||
| 1 Jan 2013 – 31 Dec 2013 | 89 | ||
| 1 Jan 2012 – 31 Dec 2012 | 58 | ||
| 1 Jan 2011 – 31 Dec 2011 | 44 | ||
| 1 Jan 2010 – 31 Dec 2010 | 45 | ||
| 1 Jan 2009 – 31 Dec 2009 | 46 | ||
| 1 Jan 2008 – 31 Dec 2008 | 41 | ||
| 1 Jan 2007 – 31 Dec 2007 | 94 | ||
| 1 Jan 2006 – 31 Dec 2006 | 77 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Per Emil Hasselbalch Stakemann | ||
| CEO | Preben Engelund Poulsen | ||
| CEO | Søren Damtoft | ||
| Board | Joachim Juel Hagemeister | Current | |
| Board | Tue Micheelsen | Current | |
| Board | Jacob Sten Petersen | Current | |
| Board | Christian Brøgger Stolberg | Current | |
| Board | Karina Sinding | Current | |
| Board | Mette Sofie Mørck Jarl | Current | |
| Board | Kurt Anker Nielsen | ||
| Board | Bjarne Mølgaard Knudsen | ||
| Board | Bjarne Mølgaard Knudsen | ||
| Board | Jørgen Grønlund Nielsen | ||
| Board | Ulf Svejgaard Poulsen | ||
| Board | Bjarne Tommy Pedersen | ||
| Board | Bent Stig Vase | ||
| Board | Susanne Saul Stakemann | ||
| Board | Keld Pedersen | ||
| Board | Hans Georg Boye Nielsen | ||
| Board | Hans Georg Boye Nielsen | ||
| Board | Sonnich Jacob Fryland | ||
| Board | Per Emil Hasselbalch Stakemann | ||
| Board | Per Andersen | ||
| Board | Kjell Hans Bakke | ||
| Board | Jonna Annelise Skovager | ||
| Board | Richardt Sonnichsen | ||
| Board | Bente Hornbech Grubbe | ||
| Board | Bente Hornbech Grubbe | ||
| Board | Jens Hartvig Jørgensen | ||
| Board | Ole Regnar Hansen | ||
| Board | Birgit Mindegaard | ||
| Board | Kim Antero Bjørnholt | ||
| Board | Jesper Frank Morthensen | ||
| Board | Bente Margrethe Skov Schultz | ||
| Board | Poul Lasse Jespersen | ||
| Board | Poul Lasse Jespersen | ||
| Board | Steen Skjold-Jørgensen | ||
| Board | Bente Margrethe Skov Schultz | ||
| Board | Erik Frederik Johannes Mortensen | ||
| Board | Eva Kjer Hansen | ||
| Board | Per Toft Valstorp | ||
| Board | Ole Falvig Ramsby | ||
| Board | Jesper Giede Bøving | ||
| Board | Kim Tosti Nielsen | ||
| Board | Jesper Frank Morthensen | ||
| Board | Louise Thiel | ||
| Board | Jesper Kløve | ||
| Board | Poul Erik Noer Søderdahl | ||
| Board | Camilla Mølbak Sønderris | ||
| Board | Lars Bjørk | ||
| Board | Susanne Møberg Hundsbæk-Pedersen | ||
| Board | Henrik Ehlers Wulff | ||
| Board | Jan Hoff | ||
| Board | Lene Due Svensson | ||
| Board | Henrik Kaj Dvinge | ||
| Board | Camilla Mølbak Sønderris | ||
| Board | Peter Helt Jacobsen Haahr | ||
| Board | Michael Fugl Hallgren | ||
| Board | Henrik Ehlers Wulff | ||
| Board | Vesna Maria Schneider | ||
| Board | Lars Sørensen | ||
| Board | Claus Steensen Sølje | ||
| Board | Søren Thor Jensen | ||
| Board | Ulla Grove Krogsgaard Thomsen | ||
| Board | Knud Edgar Striib Nielsen | ||
| Board | Jean Fabian Jeldorf | ||
| Board | Zohra Mansour | ||
| Board | Jean Fabian Jeldorf | ||
| Board | Julie Aunbirk | ||
| Board | Hazal Polat | ||
| Board | Christian Brøgger Stolberg | ||
| Board | Mette Sofie Mørck Jarl | ||
| Owner (100%) | NOVO NORDISK A/S | Current | |
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | Erik Tronborg Andersen | ||
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | VX 10.312 ApS | Current | |
| Founder | MEDIMEX ApS | Current | |
| Founder | ApS HVKMD 5 NR. 555 | Current | |
| Founder | PEHSB ApS | Current |
The CEOs' other companies
Per Emil Hasselbalch Stakemann – 45 other companies, of which 45 bankrupt
- "HEDEVANG MØBLER A/S" Bankrupt 27 Nov 1990
- "J.A.M. TRANSPORTBÅND A/S" Bankrupt 18 Aug 1993
- "NELLE'S RENGØRING A/S" Bankrupt 16 Jul 1990
- 'HG 405 PAVIA AF HIRTSHALS ApS' Bankrupt 4 Jul 2007
- 'ZOO-TEX ApS' Bankrupt 25 Nov 2016
- 02 HOLDING A/S Bankrupt 16 Oct 2008
- 09.28 ANNO 2007 ApS Bankrupt 13 Feb 2009
- 1/7 1987 A/S Bankrupt 21 Aug 2003
- 100 GB ApS Bankrupt 5 May 1994
- 11 DESIGN A/S Bankrupt 28 Apr 2015
- 1356 INVEST ApS Bankrupt 8 Apr 2011
- 15/11 1990 A/S Bankrupt 11 Oct 1994
- 15689382 ApS Bankrupt 26 Jun 2017
- 19.09.2021 ApS Bankrupt 8 Dec 2023
- 23/5 914 ApS Bankrupt 25 Jun 1991
- 3 X 65 SERVICE ApS Bankrupt 3 Mar 1997
- 3 X P A/S Bankrupt 10 Sep 1990
- 31.12.2007 X A/S Bankrupt 28 Oct 2008
- 3B DEVELOPMENT GROUP ApS Bankrupt 2 Nov 2006
- 4 FONTANE ApS Bankrupt 2 Oct 2002
- 4A MANAGEMENT ApS Bankrupt 7 May 1992
- 7 9 13 FORSIKRINGSERVICE ApS Bankrupt 20 Mar 2024
- A - INFORMATIK A/S Bankrupt 9 Oct 2013
- A J J FINANS NR. 1 ApS Bankrupt 23 Feb 1995
- A'SHARQ TV ApS Bankrupt 26 Nov 1992
- A-T SPECIALENTREPRICE ApS Bankrupt 3 Aug 2001
- A. K. OLIE ApS Bankrupt 18 Nov 2008
- A. UNO ApS Bankrupt 19 Jan 1996
- A.B. BYG ApS Bankrupt 4 Dec 1996
- A.H. GRAFIK ApS Bankrupt 23 Jan 1990
Address history (0 moves)
| Københavnsvej 216, 4600 Køge |
Former names
| Novo Nordisk Pharmatech A/S | – now |
| FEF CHEMICALS A/S | – |
| FERROSAN FINE CHEMICALS A/S | – |
| A/S PSE NR. 3369 | – |
Employees per year
Similar companies in Køge
- Nadavia Pharma ApS Køge
Questions and answers about Novo Nordisk Pharmatech A/S
Has Novo Nordisk Pharmatech A/S gone bankrupt?
No, Novo Nordisk Pharmatech A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Novo Nordisk Pharmatech A/S?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the auditor of Novo Nordisk Pharmatech A/S?
Novo Nordisk Pharmatech A/S most recently used DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was Novo Nordisk Pharmatech A/S founded?
Novo Nordisk Pharmatech A/S was founded on 1 July 1989.
What is the equity of Novo Nordisk Pharmatech A/S?
Equity was DKK 2.4bn according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.